GLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia
Redondo, Bacha (2020) GLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia J Clin Endocrinol Metab (IF: -1) 105(8) e3000-2
Full text
Click the PDF icon to view the full text of the paper
Abstract
Links
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316204http://www.ncbi.nlm.nih.gov/pubmed/32485735
http://dx.doi.org/10.1210/clinem/dgaa314
